Table 2.
Summary of results of nine examples
| Example | Total number of observed events |
Hazard ratio (95% confidence interval) at end of monitoring |
|---|---|---|
| Cerivastatin | 6 | ∞* |
| Paroxetine | 38 | 1.72 (0.89, 3.32) |
| Lisinopril | 344 | 1.92 (1.54, 2.41) |
| Ciprofloxacin | 22 | 1.45 (0.62, 3.39) |
| Rofecoxib | 1937 | 1.19 (1.09, 1.30) |
| Telithromycin | 41 | 1.26 (0.68, 2.33) |
| Rosuvastatin (diabetes) | 1914 | 0.95 (0.87, 1.04) |
| Rosuvastatin (rhabdomyolysis) | 8 | 0.39 (0.08, 1.94) |
| Celecoxib | 226 | 1.16 (0.83, 1.64) |
*
All events occurred among cerivastatin initiators